%A TAN Jia-Yu, HUANG Xiang %T Endothelial monocyte-activating polypeptide-Ⅱand tumor %0 Journal Article %D 2011 %J Journal of International Oncology %R %P 819-822 %V 38 %N 11 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_8620.shtml} %8 2011-11-08 %X Endothelial monocyte-activating polypeptide-Ⅱ (EMAP-Ⅱ) is a novel proinflammatory cytokine with proinflammatory, proapoptotic and antiangiogenic properties. It is associated with many tumor-associated proteins, such as tumor necrosis factor, vascular endothelial growth factor, hypoxia inducible factor-1α, arginyl-tRNA synthetase, and insulin-like growth factor-Ⅰ. EMAP-Ⅱ has anti-tumor properties and has a good prospect in cancer prevention and treatment.